Overview

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety of karillizumab combined with apatinib mesylate, XELOX and radiofrequency ablation
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Zhongshan Hospital Xiamen University
Treatments:
Apatinib
Capecitabine
Oxaliplatin